Cernobbio, Biroccio (Gsk): Innovation Must Be Evaluated for the Value It Generates in the Country.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.9 Articles
9 Articles
Il Tempo
Cernobbio, 5 set. (Adnkronos) - "Fortunately, there is an ever stronger innovation that comes to cure pathologies for which today there is no cure and to evaluate it only as a cost for the system would be a mistake: we must consider the value it generates for the country." So to the Adnkronos Antonino Biroccio, general manager of Gsk Italia and vice-president of Confindustria Verona for Life Sciences, interviewed on the sidelines of the Teha For…
(Adnkronos) "There is an innovation that fortunately is getting stronger and stronger to cure pathologies for which today there is no cure and to evaluate it only as a cost for the system would be a mistake: we must consider the value it generates for the country." So to the Adnkronos Antonino Biroccio, general manager of Gsk Italia and vice president of Confindustria [...]
notizie.it
Rec News | Lontani dal mainstream(Adnkronos) - "Luckily, there is an increasingly strong innovation that comes to cure pathologies for which today there is no cure and evaluate it only as
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
